ID: h-78b2af94ab
Hypothesis
Leaky Gut LPS Translocation Activates Systemic TLR4/MyD88 Signaling, Driving CNS Monocyte Infiltration
Dysbiosis compromises intestinal tight junctions (occludin, claudin-1, ZO-1) and reduces α-defensin production, permitting Gram-negative bacteria and LPS translocation into systemic circulation.
🧬 TLR4, MyD88, IRAK4, CCL2, CCR2, ZO-1 (TJP1)🩺 neurodegeneration🎯 Composite 67%💱 $0.58▼13.7%proposed
EvidencePending (0%)📖 0 cit🗣 1 debates✓ 4 support✗ 3 oppose
✓ All Quality Gates Passed
🧪 Overview
Dysbiosis compromises intestinal tight junctions (occludin, claudin-1, ZO-1) and reduces α-defensin production, permitting Gram-negative bacteria and LPS translocation into systemic circulation. Circulating LPS engages TLR4 on Kupffer cells and bone marrow monocytes, establishing chronic endotoxemia. MyD88-dependent signaling induces CCL2 (MCP-1), recruiting CCR2+ pro-inflammatory monocytes across the compromised blood-brain barrier into CNS parenchyma, where they amplify neurodegeneration.
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
flowchart TD A["Gut Dysbiosis"] -->|"disrupts"| B["Intestinal tight junction downregulation"] B -->|"allows"| C["Gram-negative bacteria and LPS translocation"] C -->|"engages"| D["TLR4 activation on Kupffer cells and monocytes"] D -->|"recruits"| E["MyD88-dependent signaling cascade"] E -->|"activates"| F["IRAK4 kinase activation"] F -->|"induces"| G["CCL2 production"] G -->|"recruits"| H["CCR2-positive inflammatory monocytes"] H -->|"traffic across"| I["Compromised blood-brain barrier"] I -->|"infiltration"| J["CNS monocyte-driven inflammation"]
⚖️ Evidence
⚖️ Evidence Matrix4 supports3 contradicts
Supports
Increased intestinal permeability documented in Parkinson's disease patients and α-synuclein transgenic mice
Supports
Blocking CCL2 reduces microglial activation and dopaminergic neuron loss in MPTP models
Contradicts
Germ-free mice paradoxically show enhanced neuroinflammatory susceptibility
Contradicts
Modern single-cell studies attribute DAM signature to resident microglia, not infiltrating monocytes
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — TLR4
🧠 GTEx v10 Brain ExpressionJSON
Median TPM across 13 brain regions for TLR4, MyD88, IRAK4, CCL2, CCR2, ZO-1 (TJP1) from GTEx v10.
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for TLR4, MyD88, IRAK4, CCL2, CCR2, ZO-1 (TJP1).
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0036
Events (7d)
1
Price History
▼13.7%💾 Resource Usage
No resource usage or linked notebooks recorded for this hypothesis yet.
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF CCR2-deficient (Ccr2-DTR or Ccr2-/-) mice are colonized with high-fat diet-induced dysbiosis or春晚FMT from LPS-challenged donors for 8 weeks, THEN despite persisting gut barrier dysfunction (reduced | >80% reduction in CNS CCR2+CD11b+Ly6Chigh monocytes despite elevated serum LPS and gut barrier compromise | — no observation — | pending | 0.58 |
| IF IRAK4 kinase activity is pharmacologically inhibited with an IRAK4 inhibitor (e.g., mesenimb or AS2444497) in a 5xFAD or APP/PS1 mouse model for 4 weeks starting at 6 months of age, THEN CNS CCR2+C | ≥40% reduction in CNS CCR2+CD11b+Ly6Chigh monocytes and ≥50% reduction in cortical CCL2 mRNA | — no observation — | pending | 0.65 |
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF IRAK4 kinase activity is pharmacologically inhibited with an IRAK4 inhibitor (e.g., mesenimb or AS2444497) in a 5xFAD or APP/PS1 mouse model for 4 weeks starting at 6 months of age, THEN CNS CCR2+CD11b+Ly6Chigh monocyte infiltration will decrease by ≥40% (measured by flow cytometry of CD45+CD11b+
Predicted outcome: ≥40% reduction in CNS CCR2+CD11b+Ly6Chigh monocytes and ≥50% reduction in cortical CCL2 mRNA
Falsification: No significant reduction in CNS monocyte counts (<20% change) or CCL2 expression; IRAK4 inhibition fails to alter peripheral LPS-induced CCL2 secretion from bone marrow monocytes in vitro
pendingconf 58%
IF CCR2-deficient (Ccr2-DTR or Ccr2-/-) mice are colonized with high-fat diet-induced dysbiosis or春晚FMT from LPS-challenged donors for 8 weeks, THEN despite persisting gut barrier dysfunction (reduced ZO-1/TJP1 expression) and elevated serum LPS (≥2 EU/mL), CNS infiltration of CCR2+CD11b+Ly6Chigh mo
Predicted outcome: >80% reduction in CNS CCR2+CD11b+Ly6Chigh monocytes despite elevated serum LPS and gut barrier compromise
Falsification: CNS monocyte infiltration persists in CCR2-/- mice despite elevated LPS; gut barrier restoration (normal ZO-1) is sufficient to prevent neuroinflammation even without CCR2 blockade, indicating paralle
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
| source | v1_phase_c_backfill |
| origin_type | debate_synthesizer |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.